Omar Shalaby
Advertisement
Mr Shalaby is a third year medical student at the Texas A&M School of medicine interested in pursuing a career in psychiatry. He is passionate about psychiatric research relating to new and innovative treatments for psychiatric illnesses.
Articles by Omar Shalaby
Due to ethical, knowledge, cost, and acceptability issues, deep brain stimulation is underutilized in disease states like treatment-resistant schizophrenia.
Advertisement
Latest Updated Articles
DBS: A Solution to Treatment-Resistant SchizophreniaPublished: May 14th 2024 | Updated:
Treatment-Resistant Schizophrenia: Can DBS Be the Solution?Published: October 23rd 2023 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
2
New Data on Lumateperone for Prevention of Relapse in Schizophrenia
3
Phase 3 Data Support CT-155 as a Novel Digital Therapeutic for Negative Symptoms in Schizophrenia at ECNP
4
Seltorexant Well-Tolerated in Adolescents as an Adjunct Treatment for Major Depressive Disorder
5
